Clinical outcomes of stereotactic ablative body radiotherapy (SABR) in medically inoperable early stage lung cancer patients

被引：0
|
作者：
Groves, Jonathan [1 ]
Yeo, Ryan [2 ]
Tsang, Yat [2 ]
Shah, Nihal [2 ]
Win, Thida [3 ]
机构：
[1] St Christopher Sch, Letchworth, Herts, England
[2] East & North Herts NHS Trust, Stevenage, Herts, England
[3] East & North Hertfordshire NHS Trust, Stevenage, Herts, England
来源：
EUROPEAN RESPIRATORY JOURNAL | 2021年 / 58卷
关键词：
Lung cancer - management; Lung cancer;
D O I：
10.1183/13993003.congress-2021.PA2293
中图分类号：
R56 [呼吸系及胸部疾病];
学科分类号：
摘要：
PA2293
引用
收藏
页数：2
相关论文
共 50 条
  • [1] Stereotactic Ablative Radiotherapy (SABR) in Patients with Medically Inoperable Peripheral Early Stage Lung Cancer: Outcomes for the First UK SABR Cohort
    Murray, L.
    Ramasamy, S.
    Lilley, J.
    Snee, M.
    Clarke, K.
    Musunuru, H. B.
    Needham, A.
    Turner, R.
    Sangha, V.
    Flatley, M.
    Franks, K.
    [J]. CLINICAL ONCOLOGY, 2016, 28 (01) : 4 - 12
  • [2] Stereotactic ablative radiotherapy for medically inoperable early stage lung cancer: early outcomes
    Chan, Oscar S. H.
    Yeung, Rebecca M. W.
    Hung, Albert W. M.
    Lee, Michael C. H.
    Chang, Amy T. Y.
    Chan, Connie C. C.
    Lee, Anne W. M.
    [J]. HONG KONG MEDICAL JOURNAL, 2012, 18 (05) : 412 - 418
  • [3] Implementation of stereotactic ablative body radiotherapy (SABR) for early stage medically inoperable lung cancer: an experience from a medium size clinical centre
    Tambe, N. S.
    Colley, W. R.
    Marsden, J. E.
    Beavis, A. W.
    Wieczorek, A.
    El-Mandawi, N.
    [J]. LUNG CANCER, 2015, 87 : S48 - S48
  • [4] Clinical stereotactic ablative body radiotherapy on patients with early-stage inoperable lung cancer
    Yeo, R.
    Nariyangadu, P.
    Shah, N.
    Tsang, Y.
    [J]. RADIOTHERAPY AND ONCOLOGY, 2021, 161 : S376 - S376
  • [5] Quality of Life and Symptoms in Patients Undergoing Stereotactic Ablative Body Radiotherapy (SABR) for Early Stage Lung Cancer
    Gray, C.
    Wingate, E.
    Ghafoor, Q.
    [J]. CLINICAL ONCOLOGY, 2018, 30 (06) : E56 - E56
  • [6] Clinical implementation of stereotactic ablative radiotherapy (SABR) for lung early stage NSCLC
    Routsis, D.
    Dean, J.
    Archer, S.
    Ferriera, C.
    [J]. RADIOTHERAPY AND ONCOLOGY, 2014, 111 : S304 - S304
  • [7] Can Dosimetry Affect Overall Survival in Patients with Medically Inoperable Peripheral Early Stage Lung Cancer Treated with Stereotactic Ablative Radiotherapy (SABR)? An Analysis of 1300 Patients
    Saha, A.
    Beasley, M.
    Clarke, K.
    Jain, P.
    Dickinson, P.
    Snee, M.
    Murray, P.
    Teo, M.
    Rodda, S. L.
    Lilley, J.
    Franks, K. N.
    [J]. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2019, 105 (01): : E529 - E529
  • [8] Safe introduction and early outcomes of stereotactic body radiotherapy for early stage medically inoperable non small cell lung cancer
    Jain, P.
    Eswar, C.
    Littler, J. A. H.
    Heaton, A.
    Scott, A.
    Mayles, H.
    [J]. LUNG CANCER, 2010, 67 : S35 - S35
  • [9] Stereotactic ablative radiotherapy (SABR) for early stage, medically inoperable non-small cell lung cancer (NSCLC): clinical outcome of 5 years of experience at the Oxford Cancer Centre
    Pascal, L.
    Bull, L.
    Ajzensztejn, D.
    Higgins, G.
    Stuart, R.
    Panakis, N.
    [J]. LUNG CANCER, 2018, 115 : S61 - S61
  • [10] Stereotactic ablative radiotherapy (SABR) in medically inoperable early stage non-small cell lung cancer (NSCLC): A single tertiary UK centre experience
    Yip, C.
    Landau, D. B.
    Thomas, C.
    Ahmad, S.
    [J]. LUNG CANCER, 2013, 79 : S58 - S58
12345